Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Alprenolol

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Alprenolol
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Pharmacokinetic data
Protein binding80% - 90%
Eliminationhalf-life2-3 hours → 4-OH-alprenolol
Identifiers
  • (RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.033.750Edit this at Wikidata
Chemical and physical data
FormulaC15H23NO2
Molar mass249.354 g·mol−1
3D model (JSmol)
  • O(c1ccccc1C\C=C)CC(O)CNC(C)C
  • InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3 checkY
  • Key:PAZJSJFMUHDSTF-UHFFFAOYSA-N checkY
  (verify)

Alprenolol, oralfeprol,alpheprol, andalprenololum (Gubernal,Regletin,Yobir,Apllobal,Aptine,Aptol Duriles), is a non-selectivebeta blocker as well as a5-HT1A and5-HT1B receptorantagonist,[1] used in the treatment ofangina pectoris.[2] It is no longer marketed byAstraZeneca, but may still be available from otherpharmaceutical companies orgenerically.

Pharmacology

[edit]

Pharmacokinetics

[edit]

Thebrain-to-blood ratio of alprenolol in humans has been found to be 16:1.[3] For comparison, the brain-to-blood ratio of the highlylipophilicpropranolol was 15:1 to 26:1 and of thehydrophilicatenolol was 0.2:1.[3]

References

[edit]
  1. ^Langlois M, Brémont B, Rousselle D, Gaudy F (1993). "Structural analysis by the comparative molecular field analysis method of the affinity of beta-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors".Eur. J. Pharmacol.244 (1):77–87.doi:10.1016/0922-4106(93)90061-d.PMID 8093601.
  2. ^Hickie JB (1970). "Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial".Med. J. Aust.2 (6):268–72.doi:10.5694/j.1326-5377.1970.tb49984.x.PMID 4393977.S2CID 6879318.
  3. ^abDrayer DE (1987). "Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers".Pharmacotherapy.7 (4):87–91.doi:10.1002/j.1875-9114.1987.tb04029.x.PMID 2891122.
β, non-selective
β1-selective
β2-selective
α1- + β-selective
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Retrieved from "https://en.wikipedia.org/w/index.php?title=Alprenolol&oldid=1299868345"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp